COMMUNIQUÉS West-GlobeNewswire

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

21/02/2025 - 22:05

Monrovia, CA, Feb. 21, 2025 (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ: EXOZ, formerly Invizyne Technologies) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, [...]

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

21/02/2025 - 22:05

MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]

Anbio Biotechnology Announces Closing of Initial Public Offering

20/02/2025 - 15:50

Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology and the provision of in vitro [...]

Serenity Medical Announces Clinical Publication of First Prospective Multicenter Trial of the River™ Stent, a Novel Venous Sinus Stent for Treating Idiopathic Intracranial Hypertension (IIH)

20/02/2025 - 15:55

Publication in the Journal of NeuroInterventional Surgery Reports Outcomes for Treatment of IIH Patients Who Are Refractory or Intolerant to Medications HARRISON, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Serenity Medical [...]

60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split

20/02/2025 - 16:36

WASHINGTON, Feb. 20, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today [...]

Acentra Health Employees Provide Over 3,000 Hours of Volunteer Work to Promote Healthier Communities

20/02/2025 - 16:45

Employee-led corporate social responsibility campaigns contributed over $332,000 in global support to improve access to food, education, and healthcare services MCLEAN, Va., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Acentra [...]

Egetis Therapeutics to Feature MCT8 Deficiency on Behind the Mystery Airing on Lifetime in Honor of Rare Disease Day

20/02/2025 - 17:00

STOCKHOLM, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Egetis Therapeutics AB (publ) (“Egetis” or the “Company”) (Nasdaq Stockholm: EGTX), an innovative pharmaceutical company specializing in late-stage development and [...]

HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)

20/02/2025 - 17:42

NEW YORK and VIENNA, Austria, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE [...]

Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy

20/02/2025 - 18:00

- Based on alignment gained with FDA under the Regenerative Medicine Advanced Therapy (RMAT) designation, Neurona plans to conduct the Phase 3 EPIC ( EPI lepsy C ell therapy) trial as the primary basis for a future NRTX [...]

OSE Immunotherapeutics présente des données précliniques positives sur l'anti-IL-7 récepteur Lusvertikimab en combinaison dans la colite chronique En présentation orale au 20ème congrès de l’ECCO

20/02/2025 - 18:05

OSE Immunotherapeutics présente des données précliniques positives sur l'anti-IL-7 récepteur Lusvertikimab en combinaison dans la colite chronique En présentation orale au 20 ème congrès de l’ECCO Nantes, France, le 20 [...]

OSE Immunotherapeutics Presents Positive Preclinical Data on Combination of Anti-IL-7 Receptor Lusvertikimab in Chronic Colitis In Oral Presentation at 20th Congress of ECCO

20/02/2025 - 18:05

OSE Immunotherapeutics Presents Positive Preclinical Data on Combination of Anti-IL-7 Receptor Lusvertikimab in Chronic Colitis In Oral Presentation at 20 th Congress of ECCO NANTES, France – February 20, 2025, 6:00pm [...]

NanoNewron and its Research to Advance the Treatment of Alzheimer’s Disease are Featured by Rutgers University Newsletters and on Rutgers Today

20/02/2025 - 18:30

UNION, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- NanoNewron, LLC (“NanoNewron” or the “Company”), a pioneering biotechnology company developing innovative, humanized biologics that cross the blood-brain barrier (BBB) to [...]

Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology

20/02/2025 - 19:30

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, immune disorders and [...]

HNL Lab Medicine Begins Subtyping Positive Flu A Samples for H5N1 Avian Influenza

20/02/2025 - 20:16

ALLENTOWN, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- In response to updated recommendations from the Centers for Disease Control and Prevention, HNL Lab Medicine will begin subtyping all positive influenza A samples from [...]

La Society for Clinical Research Sites (SCRS) et Fortrea s’associent pour promouvoir la collaboration dans le domaine de la recherche clinique

20/02/2025 - 20:51

Fortrea sponsorise le groupe de travail Collaborate Forward de la SCRS, qui encourage la collaboration pour rendre les essais cliniques plus efficaces. DURHAM, N.C., 20 févr. 2025 (GLOBE NEWSWIRE) -- La Society for [...]

National Board of Echocardiography and Inteleos Form Cardiovascular Imaging Coalition to Launch Innovative Multimodality Certification Program

20/02/2025 - 21:01

ROCKVILLE, Md., Feb. 20, 2025 (GLOBE NEWSWIRE) -- The National Board of Echocardiography (NBE) and Inteleos have established the Cardiovascular Imaging Coalition (CVIC) to streamline the maintenance of certification ( [...]

HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)

20/02/2025 - 21:06

NEW YORK and VIENNA, Austria, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE [...]

Clinical Effects Voted #1 in Natural Wellness & Customer Satisfaction

20/02/2025 - 21:18

Clinical Effects Earns Top Recognition for Its Commitment to Clean, Science-Backed Wellness Solutions That Support Holistic Health Boise, Feb. 20, 2025 (GLOBE NEWSWIRE) -- In a market filled with wellness brands making [...]

Inventiva et Hepalys Pharma, Inc. annoncent le lancement du programme de développement clinique de lanifibranor au Japon avec l'inclusion du premier participant dans l'étude de Phase 1

20/02/2025 - 22:00

Lancement du programme de développement clinique de lanifibranor au Japon avec l'inclusion du premier participant à l'étude de Phase 1 Des résultats positifs pourraient supporter le lancement d'une étude de Phase 3 [...]